The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients

Neuropsychopharmacology

Volumn 15, Issue 4, 1996, Pages 361-369

  Hoff, Anne L ^a,c   Faustman, William O ^b,c   Wieneke, Mary ^a   Espinoza, Scott ^a   Costa, Martin ^a   Wolkowitz, Owen ^d   Csernansky, John G ^e  

^a Napa State Hospital   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clozapine; Cognition; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0030272374     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00242-6     Document Type: Article

References (36)

1. Benton AL (1974): The Revised Visual Retention Test, ed. 4. New York, Psychological Corporation
2. Benton AL, Hamsher K de S (1989): Multilingual Aphasia Examination. Iowa City, University of Iowa, AJA Associates
3. Breier A, Buchanan RW, Irish D, Carpenter WT Jr (1993): Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns. Hosp Comm Psychiatry 44:1145-1149
4. Buchanan RW, Holstein C, Brier A (1994): The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 36:717-725
5. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG (1990): Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schiz Bull 16:477-499
6. Chiles JA, Davidson P, McBride D (1994): Effects of clozapine on use of seclusion and restraint at a state hospital. Hosp Comm Psychiatry 45:269-271
7. Delis D, Kramer J, Kaplan E, Ober B (1987): California Verbal Learning Test: Research Edition. San Antonio, Psychological Corporation
8. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49:538-544
9. Faustman WO (1994): Brief Psychiatric Rating Scale. In Maruish ME (ed), The Use of Psychological Testing for Treatment Planning and Outcome Assessment. Hillsdale, NJ, Erlbaum, pp 371-401
10. Faustman WO, Hoff AL (1996): Effects of antipsychotic drugs on neuropsychological measures. In Csernansky JG (ed), Handbook of Experimental Pharmacology: Antipsychotics. Berlin, Springer-Verlag, pp 445-477
11. Goldberg TE, Weinberger DR (1994): The effects of clozapine on neurocognition. J Clin Psychiatry (suppl B) 55:88-90
12. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schultz SC, Weinberger DR (1993): The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Brit J Psychiatry 162:43-48
13. Goodglass H, Kaplan E (1983): The Assessment of Aphasia and Related Disorders. Philadelphia, Lea & Febiger
14. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY (1993): Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 34:702-712
15. Heaton RK (1981): Wisconsin Card Sorting Test (WCST). Manual. Odessa, Florida, Psychological Assessment Resources.
16. Hedlund JL, Vieweg BW (1980): The Brief Psychiatric Rating Scale (BPRS): A comprehensive review. J Oper Psychiatry 11:48-64
17. Hoff AL, Riordan H, O'Donnell D, Morris L, DeLisi LE (1992a): Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 149:898-903
18. Hoff AL, Riordan H, O'Donnell D, Stritzke P, Neale C, Boccio A, Anand A, DeLisi LE (1992b): Anomalous lateral sulcus asymmetry and cognitive function in first-episode schizophrenia. Schiz Bull 18:257-272
19. Jastak S, Wilkinson G (1984): The Wide Range Achievement Test-Revised. Wilmington, DE, Jastak Associates
20. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group (1988): Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chloromazine. Arch Gen Psychiatry 45:789-796
21. King DJ (1990): The effect of neuroleptics on cognitive and psychomotor function. Brit J Psychiatry 157:799-811
22. Kraemer H, Thiemann S (1987): How Many Subjects? Statistical Power Analysis in Research. Newbury Park, CA, Sage
23. Lee MA, Thompson PA, Meltzer HY (1994): Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry (suppl B) 55:82-87
24. Lieberman JA, Johns CA, Kane JM et al. (1988): Clozapine-induced agranulocytosis: Noncross reactivity with other psychotropic drugs. J Clin Psychiatry 49:271-277
25. Meltzer HY (1992): Dimensions of outcome with clozapine. Br J Psychiatry (suppl. 17) 160:46-53
26. Meltzer HY (1994): An overview of the mechanism of action of clozapine. J Clin Psychiatry (suppl B) 55:47-52
27. Meltzer HY, Burnett S, Bastani B, Ramirez LF (1990): Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Comm Psychiatry 41:892-897
28. Nelson HE, McKenna P (1975): The use of reading ability in the assessment of dementia. Brit J Soc Clin Psychol 14:259-267
29. Overall JE, Gorham DR (1962): The Brief Psychiatric Rating Scale. Psych Reports 10:799-812
30. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH (1992): Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine. Arch Gen Psychiatry 49:345-353
31. Reitan RM (1979): Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tucson, AZ, Ralph M. Reitan
32. Satz P, Mogel S (1962): An abbreviation of the WAIS for clinical use. J Clin Psychology 18:77-79
33. Smith A (1973): Symbol Digit Modalities Test: Manual. Los Angeles, Western Psychological Services
34. Spitzer RL, Williams JBW, Gibbon M, First MB (1992): The structured clinical interview for DSM-III-R (SCID). I History, rationale, and description. Arch Gen Psychiatry 49:630-636
35. Thiemann S, Csernansky JG, Berger PA (1987): Rating Scales in research: The case of negative symptoms. Psychiatry Res 20:47-55
36. Wechsler DA (1945): A standardized memory scale for clinical use. J Psychology 19:87-95